Nanna Maria Andersen,Ásthildur Árnadóttir,Tora Grauers Willadsen,Gritt Overbeck

DOI: https://doi.org/10.1080/02813432.2024.2407877

Scandinavian Journal of Primary Health Care

Abstract:Introduction The prevalence of sleep disorders and use of sleep medication, particularly melatonin, are rising among adolescents and young adults (13–24 years). In Denmark, melatonin is approved for use in children with autism and ADHD up to 18 years of age, with other prescriptions being off-label in these age groups. The perspectives of medical practitioners on prescribing sleep medications to this age group remain largely unexplored.

medicine, general & internal,health care sciences & services,primary health care

What problem does this paper attempt to address?

Medical practitioners' experiences and considerations when managing sleep medication for adolescents and young adults